ProNovo
Precision Medicines. Personal Relief. A New Era in Mental Health.
- Headquarters
- San Diego, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- pronovotx.com
About
ProNovo Therapeutics is a San Diego, California-based biotechnology company developing precision therapeutics for neuropsychiatric disorders including Major Depressive Disorder and Schizophrenia. The company leverages genetic susceptibility data, disease pathophysiology, and prognostic biomarkers to develop novel small molecule treatments targeting emerging neuropsychiatric pathways. ProNovo closed a seed financing round in April 2025 led by K2 Venture, with participation from 3E Bioventures Capital, Gaorong Ventures, and JLS Fund.
Summary
ProNovo is a Biotech company based in San Diego, United States.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company